Sanofi
ROR gamma (RORy) modulators
Last updated:
Abstract:
The present invention relates to compounds according to Formula I: or a pharmaceutically acceptable salt thereof. The compounds can be used as inhibitors of RORy and are useful for the treatment of RORy mediated diseases such as autoimmune and inflammatory diseases. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
3 Jun 2016
Issue date:
1 Oct 2019